General Information of the Compound
| Compound ID |
CP0047923
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
BMY-40900
Show/Hide
|
||||||||||||||||||
| Synonyms |
69655-05-6
9-(2,3-Dideoxy-beta-D-ribofuranosyl)-6-oxopurine
9-[(2R,5R)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL]-1,9-DIHYDRO-6H-PURIN-6-ONE
9-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,9-dihydro-6H-purin-6-one
BMY 40900
BMY-40900
CHEBI:490877
DDI
DIDEOXYINOSINE
DRG-0016
DSSTox_CID_2927
Didanosina
Didanosina [INN-Spanish]
Didanosine
Didanosinum
Didanosinum [INN-Latin]
Inosine, 2',3'-dideoxy-
K3GDH6OH08
NCGC00090691-03
NCGC00159514-02
NSC 612049
UNII-K3GDH6OH08
Videx
Videx EC
ddIno
didanosine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C10H12N4O3
|
||||||||||||||||||
| Molecular Weight |
236.231
|
||||||||||||||||||
| Canonical SMILES |
OC[C@@H]1CC[C@@H](O1)n1cnc2c1nc[nH]c2=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C10H12N4O3/c15-3-6-1-2-7(17-6)14-5-13-8-9(14)11-4-12-10(8)16/h4-7,15H,1-3H2,(H,11,12,16)/t6-,7+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
BXZVVICBKDXVGW-NKWVEPMBSA-N
|
||||||||||||||||||
| CAS |
69655-05-6
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound